Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 19, 2010 - Issue 9
Submit an article Journal homepage
237
Views
10
CrossRef citations to date
0
Altmetric
Reviews

New small molecules for the treatment of Parkinson's disease

Thomas Müller St. Joseph Hospital Berlin-Weissensee, Department of Neurology, Gartenstrasse 1, 13088 Berlin, Germany +49 30 92790223; +49 30 92790703; [email protected]
, MD
Pages 1077-1086 | Published online: 20 Jul 2010

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gaia Skibinski & Steven Finkbeiner. (2011) Drug discovery in Parkinson's disease: update and developments in the use of cellular models. International Journal of High Throughput Screening 2, pages 15-25.
Read now

Articles from other publishers (9)

Ana Ortíz de Zárate, Marta Pérez-Torralba, Iñigo Bonet Isidro, Concepción López, Rosa M. Claramunt, Diana Martínez-Casanova, Isabel Sánchez-Vera, Jesús Jiménez-González & José Luis Lavandera. (2021) 1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents. Antioxidants 10:10, pages 1584.
Crossref
Thomas Müller. (2019) Therapiefreiheit zwischen gesetzlichem Rahmen und Zulassungsverfahren. NeuroTransmitter 30:10, pages 16-21.
Crossref
Kewal K. JainKewal K. Jain. 2019. The Handbook of Neuroprotection. The Handbook of Neuroprotection 403 463 .
Carla Nieto, María Cornago, María Cabildo, Dionisia Sanz, Rosa Claramunt, María Torralba, María Torres, Diana Martínez Casanova, Yaiza Sánchez-Alegre, Esther Escudero & José Lavandera. (2018) Evaluation of the Antioxidant and Neuroprotectant Activities of New Asymmetrical 1,3-Diketones. Molecules 23:8, pages 1837.
Crossref
Simon Loiodice, Anne-Sophie Denibaud, Wendy Deffains, Magali Alix, Pierre Montagne, Marine Seffals & Christophe Drieu La Rochelle. (2017) Validation of a New Scoring Scale for Behavioral Assessment of L-Dopa-Induced Dyskinesia in the Rat: A New Tool for Early Decision-Making in Drug Development. ACS Chemical Neuroscience 9:4, pages 762-772.
Crossref
J. Guridi, R. González-Redondo & J. A. Obeso. (2012) Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Parkinson's Disease 2012, pages 1-15.
Crossref
Sonia Gandhi & Andrey Y. Abramov. (2012) Mechanism of Oxidative Stress in Neurodegeneration. Oxidative Medicine and Cellular Longevity 2012, pages 1-11.
Crossref
Philip Y. Lam & Kam Ming Ko. (2012) Schisandrin B as a Hormetic Agent for Preventing Age-Related Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2012, pages 1-9.
Crossref
Kewal K. JainKewal K. Jain. 2011. The Handbook of Neuroprotection. The Handbook of Neuroprotection 297 336 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.